These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16799469)
41. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173 [TBL] [Abstract][Full Text] [Related]
42. Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Lee K; Erturk E; Mayer R; Cockett AT Cancer Res; 1987 Oct; 47(19):5021-4. PubMed ID: 2441860 [TBL] [Abstract][Full Text] [Related]
43. [An experimental research on the combination treatment of sFLK-1 gene therapy combined with gamma knife]. Chen J; Wang ZR; Li H; Wei YQ; Wang W; Zhu B Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):708-11, 716. PubMed ID: 17037733 [TBL] [Abstract][Full Text] [Related]
45. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice. Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369 [TBL] [Abstract][Full Text] [Related]
46. [Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice]. Niu T; Liu T; Jia YQ; Liu JY; Wu Y; Hu B; Tian L; Yang L; Kan B; Wei YQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):661-4, 675. PubMed ID: 16235531 [TBL] [Abstract][Full Text] [Related]
47. Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Hayashi S; Mizuno M; Yoshida J; Nakao A Cancer Gene Ther; 2009 Aug; 16(8):638-43. PubMed ID: 19498458 [TBL] [Abstract][Full Text] [Related]
48. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics. Sini P; Samarzija I; Baffert F; Littlewood-Evans A; Schnell C; Theuer A; Christian S; Boos A; Hess-Stumpp H; Foekens JA; Setyono-Han B; Wood J; Hynes NE Cancer Res; 2008 Mar; 68(5):1581-92. PubMed ID: 18316624 [TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548 [TBL] [Abstract][Full Text] [Related]
51. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740 [TBL] [Abstract][Full Text] [Related]
52. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348 [TBL] [Abstract][Full Text] [Related]
53. Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent. Pajtasz-Piasecka E; Kuśnierczyk H; Salwa J; Konarski L; Radzikowski C Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):281-92. PubMed ID: 8744648 [TBL] [Abstract][Full Text] [Related]
54. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro. Sarna S; Bhola RK Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874 [TBL] [Abstract][Full Text] [Related]
55. Tumor regression by targeted gene delivery to the neovasculature. Hood JD; Bednarski M; Frausto R; Guccione S; Reisfeld RA; Xiang R; Cheresh DA Science; 2002 Jun; 296(5577):2404-7. PubMed ID: 12089446 [TBL] [Abstract][Full Text] [Related]
56. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments. Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897 [TBL] [Abstract][Full Text] [Related]
57. EPR oximetry of tumors in vivo in cancer therapy. Sentjurc M; Cemazar M; Sersa G Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1379-85. PubMed ID: 15134738 [TBL] [Abstract][Full Text] [Related]
58. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW J Control Release; 2005 Jan; 101(1-3):273-85. PubMed ID: 15588911 [TBL] [Abstract][Full Text] [Related]
59. Effects of matrix-associated chemotherapy in combination with irradiation in vivo. Howes AE; Herman TS; Montoya VP; Luck EE; Brown DM NCI Monogr; 1988; (6):141-3. PubMed ID: 3352756 [TBL] [Abstract][Full Text] [Related]
60. Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotides. van der Most RG; Himbeck R; Aarons S; Carter SJ; Larma I; Robinson C; Currie A; Lake RA J Immunother; 2006; 29(2):134-42. PubMed ID: 16531814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]